Chang David D
Director, President and CEO · 2 filings · Latest: Mar 16, 2026
Allogene Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ALLO | Chang David D | Director, President and CEO | Mar 16, 2026 | Sale | $2.47 | 47,763 | $118.0K | 5,150,599 | |
ALLO | Chang David D | — | Mar 16, 2026 | Proposed Sale | $2.47 | 47,763 | $117.8K | — | |
ALLO | Chang David D | Director, President and CEO | Feb 2, 2026 | Sale | $1.80 | 95,269 | $171.5K | 5,185,862 | |
ALLO | DAVID CHANG | — | Feb 2, 2026 | Proposed Sale | $1.80 | 243,976 | $438.5K | — | |
ALLO | Chang David D | — | Mar 14, 2025 | Proposed Sale | $1.96 | 46,668 | $91.5K | — | |
ALLO | Chang David D | — | Feb 3, 2025 | Proposed Sale | $1.68 | 46,003 | $77.4K | — |